Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

BUY
$1.3 - $2.64 $2,797 - $5,681
2,152 New
2,152 $4,000
Q4 2021

Jan 24, 2022

SELL
$2.92 - $5.74 $1,559 - $3,065
-534 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$4.98 - $6.63 $2,659 - $3,540
534 New
534 $3,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.